< Back to all Breaking News
GNMSF
4/27/2015 10:04am
Genmab announces Phase III study of Arzerra met primary endpoint 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
